Back to FMR LLC FMR LLC

QNCX

19 quarters

Position history for FMR LLCFMR LLC's holdings in QUINCE THERAPEUTICS INC

No. FMR exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 70 shares worth $235. FMR already held QNCX in its Q3 2019 13F, the earliest on record, and held it in 14 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$221,000

Total Shares Change

-8,847

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$20.20
0
2025-Q4
New
70
-
$2350.0%$670.00
17
2025-Q2
Exited
0
-100.0%
$00.0%$330.00
0
2025-Q1
New
50
-
$670.0%$266.00
17
2024-Q2
Exited
0
-100.0%
$00.0%$150.00
0
2024-Q1
New
1,500
-
$1,5900.0%$212.00
17
2022-Q3
Exited
0
-100.0%
$00.0%$266.00
0
2022-Q2
Decreased
379
-53.7%
$8410.0%$444.00
0
2022-Q1
New
818
-
$5,0630.0%$1,238.00
23
2021-Q4
Exited
0
-100.0%
$00.0%$2,524.00
0
2021-Q3
Unchanged
1,947
0.0%
$178,0000.0%$18,332.00
0
2021-Q2
Unchanged
1,947
0.0%
$103,0000.0%$10,600.00
0
2021-Q1
Unchanged
1,947
0.0%
$70,0000.0%$7,206.00
0
2020-Q4
Decreased
1,947
-20.4%
$54,0000.0%$5,556.00
0
2020-Q3
Decreased
2,447
-72.3%
$122,0000.0%$10,000.00
0
2020-Q2
Unchanged
8,847
0.0%
$410,0000.0%$9,260.00
0
2020-Q1
Unchanged
8,847
0.0%
$404,0000.0%$9,122.00
0
2019-Q4
Unchanged
8,847
0.0%
$497,0000.0%$11,228.00
0
2019-Q3
First report
8,847
-
$221,0000.0%$4,986.00
0

Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used